Cargando…

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma

GSDM family is a group of critical proteins that mediate pyroptosis and plays an important role in cell death and inflammation. However, their specific function in clear cell renal cell carcinoma (ccRCC, KIRC) have not been clarified comprehensively. In this study, we assessed the roles of the GSDM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Lei, Li, Juanni, Xu, Zhijie, Yan, Yuanliang, Hu, Kuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004560/ https://www.ncbi.nlm.nih.gov/pubmed/35321945 http://dx.doi.org/10.18632/aging.203973

Ejemplares similares

Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma
por: Hu, Kuan, et al.
Publicado: (2021)

Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022)

Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Hu, Kuan, et al.
Publicado: (2022)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Tian, Junjie, et al.
Publicado: (2023)

Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration
por: Hu, Kuan, et al.
Publicado: (2021)

Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma
por: Zhu, Tong, et al.
Publicado: (2022)

Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma
por: Guo, Hongda, et al.
Publicado: (2022)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma
por: Shao, Yuan, et al.
Publicado: (2023)

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma
por: Zang, Yuanwei, et al.
Publicado: (2017)

An integrative pan cancer analysis of RET aberrations and their potential clinical implications
por: Zhou, Lei, et al.
Publicado: (2022)

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
por: Li, Juanni, et al.
Publicado: (2021)

YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2021)

Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma
por: Wang, Ganggang, et al.
Publicado: (2022)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
por: Palomero, Luis, et al.
Publicado: (2020)

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Gong, Yun, et al.
Publicado: (2022)

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
por: Xiang, Zhenfei, et al.
Publicado: (2021)

ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
por: Zhang, Chiyu, et al.
Publicado: (2022)

Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma
por: Wang, Zengzeng, et al.
Publicado: (2018)

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014)

Copy number variations and expression of MPDZ are prognostic biomarkers for clear cell renal cell carcinoma
por: Huang, Yong-Sheng, et al.
Publicado: (2017)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2021)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
por: Li, Juanni, et al.
Publicado: (2020)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2023)

Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020)

Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2014)

Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gt1b5slipdvrjnqg8vf341omsb